Thorsten Naumann serves as the R&D GERMANY - Peptide & Oligonucleotide Platform Leader and Head of Development Science & Innovation at EUROAPI since November 2021, overseeing a team of experts in Process Development and industrial transfer focused on supporting external CDMO clients. Previously, from May 2005 to November 2021, Thorsten Naumann held various leadership roles at Sanofi, including Head of the TIDES Platform, where responsibilities included building a comprehensive development organization for Oligonucleotides, Peptides, and Modified Large synthetic Molecules, and Global Head of Pre-Development Sciences, ensuring connectivity between research and development. Earlier positions included Head of Hub Management Office at Sanofi and Head of Computer Aided Drug Design at Aventis Deutschland GmbH. Thorsten Naumann began a career in the pharmaceutical industry as an Application Scientist at Tripos after earning a PhD in Chemistry from Goethe University Frankfurt between 1994 and 1996.
This person is not in any teams
This person is not in any offices